Multivariate Optimization of the Refolding Process of an Incorrectly Folded Fc-Fusion Protein in a Cell Culture Broth

Abstract

Background: Protein misfolding is a common problem in large-scale production of recombinant proteins, which can significantly reduce the yield of the process. Objective: In this work, we aimed at treating a cell culture broth containing high levels (>45%) of incorrectly folded Fc-fusion proteins by a simple redox buffer system in order to increase the proportion of the protein with correct conformation. Methods: Multi-variable process optimization was firstly conducted at a small scale (25 mL), employing an experimental design methodology. After identifying the key variables using a resolution IV Fractional Factorial Design (FFD), the process was then optimized by the Central Composite Design (CCD). Results: The optimal conditions for the refolding reaction were 340 mM Tris-base, 6.0 mM L-cysteine, 0.5 mM L-cystine, a buffer pH of 9.0, a reaction temperature of 8.5ºC and a reaction time of 24 h. Based on the treatment conditions obtained at a small scale, the process was further scaled up to 4500- L. The misfolded content was always less than 20%. The reaction can proceed well in the absence of chemical additives, such as chaotropic agents, aggregation suppressors, stabilizers and chelators. Conclusion: The refolding process increases the fraction of active protein in the original broth reducing the burden on downstream purification steps markedly.

Enhanced metabolism and negative regulation of ER stress support higher erythropoietin production in HEK293 cells

“…Although human-derived cell lines benefit from the ability to generate human PTMs, challenges still remain, such as increasing the protein production titer (Chin et al, 2019;Dietmair et al, 2012;Mori et al, 2020) and creating a genetic engineering toolbox with specialized tools for human cells (Xu and Qi 2019). Recent publications have pursued some of these challenges, including the aim to increase the protein production and secretion power either by cell-line development approaches (Chin et al, 2019;Rahimpour et al, 2013) or cell culture process optimization (Schwarz et al, 2019), as well as to increase the quality of the secreted proteins by engineering folding and PTM pathways (Meuris et al, 2014;Del Val et al, 2016;Liang et al, 2020;Behrouz et al, 2020). However, despite the current knowledge of protein production and secretion in eukaryotic cells, there is still notable ambiguity in understanding and predicting the production and secretion rates as well as product quality under different conditions (Kafri et al, 2016;Liu et al 2016).…”

Optimized Production of Fc Fusion Proteins by Sortase Enzymatic Ligation

“…Advances in antibody engineering have led to the development of Fc domains with enhanced pharmacokinetic properties and tailored immune pathway activation or suppression mechanisms. − These advanced Fc protein designs have further increased the utility of Fc fusions as a mechanism for targeted protein drug development with enhanced drug pharmacokinetic properties. However, cell-based production of novel and non-native Fc fusions can be challenging as a result of potentially low expression titers, , enzymatic degradation, − misfolding, , and aggregation . In contrast to direct molecular expression, synthetic approaches to form fusion proteins allow each component to be separately expressed in an optimal expression platform prior to chemical or enzymatic conjugation, potentially increasing accessibility to diverse Fc fusion concepts.…”

Using MVDA with stoichiometric balances to optimize amino acid concentrations in chemically defined CHO cell culture medium for improved culture performance

“…Dietmair et al utilized PLS to determine a range of metabolites in the culture medium that correlate with the cell growth rate (Dietmair et al, 2012). In most cases, MVDA models have provided support in upstream bioprocess development, process characterization, platform development, and more recently, media development that drive specific responses (Behrouz et al, 2020;MKS Umetrics AB, 2013;Pybus et al, 2014;Worley & Powers, 2013). Therefore, we hypothesized that amino acid SBs used in combination with MVDA models, could not only highlight key amino acids, but also provide information on cell culture performance characteristics.…”